Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of YMC026 in patients with respiratory disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Disease

Drugs mentioned

• YMC026

Snippet

Sponsor: Yuhan Corporation | Conditions: Respiratory Disease | Phase 4 | Status: COMPLETED